A

Agenus

294 employees

Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Immuno-oncology
Checkpoint Inhibitors and Modulators
Therapeutics
Immunotherapy
Cancer Vaccines
Cell therapy
GMP Manufacturing
Medical Device
Medical
Antibodies

Date founded

1994

Funding rounds raised

Total raised

$60M

from 2 investors over 2 rounds

A

Agenus raised $60M on February 14, 2017

Investors: Incyte

A

Agenus raised $10M on August 4, 2009

Investors: Hudson Capital Management LLC

FAQ